// App-Quantinova.ai

FRI0318 (2018) : Health care resource utilisation (HCRU and cost analyses of systemic lupus erythematosus (SLE as a function of disease severity: analysis of real-world claims data from a german sickness fund

Researchers

Presenter

  • E.R. Hammond

Principal Investigators

  • H. Friedel

  • E. Garal-Pantaler

  • M. Pignot

  • E. Velthuis

  • X. Wang

  • H. Nab

  • B. Desta

  • A. Schwarting

Medical Centers

  • AstraZeneca, Gaithersburg, MD

  • Team Gesundheit GmbH, Essen, Germany

  • Kantar Health GmbH, Munich, Germany

  • Evidera PPD, Utrecht Area, Netherlands

  • AstraZeneca, Cambridge, MA

  • Universitatsmedizin der Johannes Gutenberg-Universitat Mainz, Mainz, Germany

Locations

  • United States

  • Germany

  • Netherlands

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Lupus

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A